<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0001">
 <label>Table 1</label>
 <caption>
  <p>List of candidate therapeutic drugs for SARS-CoV-2 therapy in clinical trials.</p>
 </caption>
 <alt-text id="alt0009">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="top">Category</th>
    <th valign="top">Candidate therapeutics</th>
    <th valign="top">Modality</th>
    <th valign="top">Manufacturer</th>
    <th valign="top">Status of clinical trials</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="3" align="left" valign="top">Nucleoside Analogs</td>
    <td valign="top">Pegylated interferon with ribavirin 
     <xref rid="bib0077" ref-type="bibr">[77]</xref>
    </td>
    <td valign="top">/</td>
    <td valign="top">Valeant</td>
    <td valign="top">Under clinical trial for COVID-19 (ChiCTR2000029387)</td>
   </tr>
   <tr>
    <td valign="top">Favipiravir (T-705) 
     <xref rid="bib0078" ref-type="bibr">[78]</xref>
    </td>
    <td valign="top">A guanine analog for the treatment of influenza virus infections</td>
    <td valign="top">Toyama</td>
    <td valign="top">Under clinical trial for COVID-19 (ChiCTR2000029548)</td>
   </tr>
   <tr>
    <td valign="top">Remdesivir 
     <xref rid="bib0079" ref-type="bibr">[79]</xref> (GS-5734)
    </td>
    <td valign="top">An adenine analog with a similar chemical structure to the approved HIV reverse transcriptase inhibitor tenofovir alafenamide.</td>
    <td valign="top">Gilead</td>
    <td valign="top">Phase II clinical trial for Ebola
     <break/>(NCT03719586);
     <break/>Under phase III clinical trials for COVID-19 (NCT04252664)
    </td>
   </tr>
   <tr>
    <td valign="top">Type I interferons</td>
    <td valign="top">IFN-Î²1 
     <xref rid="bib0080" ref-type="bibr">[80]</xref>
    </td>
    <td valign="top">Used as a treatment for multiple sclerosis</td>
    <td valign="top">Multiple companies</td>
    <td valign="top">Treatment of COVID-19 in the early stage</td>
   </tr>
   <tr>
    <td valign="top">Protease inhibitors</td>
    <td valign="top">Lopinavir and ritonavir 
     <xref rid="bib0076" ref-type="bibr">[76]</xref>
    </td>
    <td valign="top">Protease inhibitors approved as anti-HIV drugs</td>
    <td valign="top">Abbott</td>
    <td valign="top">Under clinical trials for SARS; Under clinical trial for COVID-19 (ChiCTR2000029539)</td>
   </tr>
   <tr>
    <td valign="top">Chloroquine</td>
    <td valign="top">Chloroquine and hydroxychloroquine 
     <xref rid="bib0081" ref-type="bibr">[81]</xref>
    </td>
    <td valign="top">Oral prescription drugs for treatment of malaria and certain inflammatory conditions</td>
    <td valign="top">Multiple companies</td>
    <td valign="top">Under investigation in clinical trials for pre-exposure or post-exposure prophylaxis of SARS-CoV-2 infection</td>
   </tr>
   <tr>
    <td valign="top">Antibodies</td>
    <td valign="top">CR3022 
     <xref rid="bib0082" ref-type="bibr">[82]</xref>
    </td>
    <td valign="top">A SARS Cov-specific human monoclonal antibody</td>
    <td valign="top">Multiple companies</td>
    <td valign="top">Experimental phase</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
